Average Co-Inventor Count = 2.97
ph-index = 39
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (62 from 665 patents)
2. Incyte Holdings Corporation (30 from 147 patents)
3. Bristol-myers Squibb Pharma Company (7 from 234 patents)
4. Dupont Pharmaceuticals Company (5 from 106 patents)
5. The Dupont Merck Pharmaceutical Company (4 from 206 patents)
6. Bristol-myers Squibb Compnay (2 from 3,681 patents)
7. E.i. Dupont De Nemours and Company (1 from 16,338 patents)
8. Dupont Pharmaceuticals, Inc. (1 from 15 patents)
9. Bristol-myers Squibb Pharma Corporation (1 from 10 patents)
10. Incyte Incorporation (1 from 4 patents)
11. Ineyte Corporation (1 from 1 patent)
12. Incyte Cororation (1 from 1 patent)
86 patents:
1. 11744832 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
2. 11498926 - Tricyclic heterocycles as BET protein inhibitors
3. 11331320 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
4. 11213528 - Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
5. 11091484 - Tricyclic heterocycles as BET protein inhibitors
6. 10975085 - Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula III
7. 10919912 - Tricyclic heterocycles as BET protein inhibitors
8. 10640506 - Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
9. 10639310 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
10. 10610530 - Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
11. 10463667 - Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12. 10464947 - Tricyclic heterocycles as BET protein inhibitors
13. 10442803 - Tricyclic heterocycles as bet protein inhibitors
14. 10398699 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
15. 10364248 - Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidine